These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24570327)

  • 1. Prevention of contrast-induced nephropathy with prostaglandin E1 in high-risk patients undergoing percutaneous coronary intervention.
    Li WH; Li DY; Qian WH; Liu JL; Xu TD; Zhu H; He HY
    Int Urol Nephrol; 2014 Apr; 46(4):781-6. PubMed ID: 24570327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of nicorandil treatment for prevention of contrast-induced nephropathy in high-risk patients undergoing cardiac catheterization: A prospective randomized controlled trial.
    Iranirad L; Hejazi SF; Sadeghi MS; Jang SA
    Cardiol J; 2017; 24(5):502-507. PubMed ID: 28281738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of alprostadil in preventing contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: A multicenter prospective randomized controlled trial.
    Liang M; Yang S; Fu N; Lu C; Tian F; Xing X; Lin W; Liu J
    Catheter Cardiovasc Interv; 2018 Mar; 91(4):742-750. PubMed ID: 29024304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of contrast-induced nephropathy with prostaglandin E1 in patients undergoing percutaneous coronary procedures: A meta-analysis of 24 randomized controlled trials
.
    Liu X; Hang Y; Shen L; Yang J; Zhou L; Sha W; Lu G
    Clin Nephrol; 2018 Nov; 90(5):313-324. PubMed ID: 30106366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHA2DS2-VASC score as a preprocedural predictor of contrast-induced nephropathy among patients with chronic total occlusion undergoing percutaneous coronary intervention: a single-center experience.
    Wang Y; Zhao HW; Zhang XJ; Chen BJ; Yu GN; Hou AJ; Luan B
    BMC Cardiovasc Disord; 2019 Mar; 19(1):74. PubMed ID: 30922230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of alprostadil on preventing contrast-induced nephropathy for percutaneous coronary intervention in diabetic patients: A systematic review and meta-analysis.
    Ye Z; Lu H; Guo W; Dai W; Li H; Yang H; Li L
    Medicine (Baltimore); 2016 Nov; 95(46):e5306. PubMed ID: 27861357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventive Effects of Alprostadil Against Contrast-Induced Nephropathy Inpatients With Renal Insufficiency Undergoing Percutaneous Coronary Intervention.
    Yang SC; Fu NK; Zhang J; Liang M; Cong HL; Lin WH; Tian FS; Lu CZ; Sun TT; Zhang WY; Ma ZH
    Angiology; 2018 May; 69(5):393-399. PubMed ID: 29073785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a Contrast Modulation System on Contrast Media Use and the Rate of Acute Kidney Injury After Coronary Angiography.
    Mehran R; Faggioni M; Chandrasekhar J; Angiolillo DJ; Bertolet B; Jobe RL; Al-Joundi B; Brar S; Dangas G; Batchelor W; Prasad A; Gurm HS; Tumlin J; Stone GW
    JACC Cardiovasc Interv; 2018 Aug; 11(16):1601-1610. PubMed ID: 30139467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Alprostadil on the Prevention of Contrast-Induced Nephropathy: A Meta-Analysis of 36 Randomized Controlled Trials.
    Xie J; Jiang M; Lin Y; Deng H; Li L
    Angiology; 2019 Aug; 70(7):594-612. PubMed ID: 30669852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium bicarbonate plus isotonic saline versus saline for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: a randomized controlled trial.
    Vasheghani-Farahani A; Sadigh G; Kassaian SE; Khatami SM; Fotouhi A; Razavi SA; Mansournia MA; Yamini-Sharif A; Amirzadegan A; Salarifar M; Sadeghian S; Davoodi G; Borumand MA; Esfehani FA; Darabian S
    Am J Kidney Dis; 2009 Oct; 54(4):610-8. PubMed ID: 19619921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of high loading dose of atorvastatin in diabetic patients with renal dysfunction undergoing elective percutaneous coronary intervention: a randomized controlled trial.
    Shehata M; Hamza M
    Cardiovasc Ther; 2015 Apr; 33(2):35-41. PubMed ID: 25677920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alprostadil plays a protective role in contrast-induced nephropathy in the elderly.
    Miao Y; Zhong Y; Yan H; Li W; Wang BY; Jin J
    Int Urol Nephrol; 2013 Aug; 45(4):1179-85. PubMed ID: 23860961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventive effect of oral nicorandil on contrast-induced nephropathy in patients with renal insufficiency undergoing elective cardiac catheterization.
    Fan Y; Wei Q; Cai J; Shi Y; Zhang Y; Yao L; Wang X; Lin S; Li Y; Lv J; Zhou B; Du R
    Heart Vessels; 2016 Nov; 31(11):1776-1782. PubMed ID: 26874946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alprostadil protects type 2 diabetes mellitus patients treated with metformin from contrast-induced nephropathy.
    Wang J; Ai X; Li L; Gao Y; Sun N; Li C; Sun W
    Int Urol Nephrol; 2017 Nov; 49(11):2019-2026. PubMed ID: 28656510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast-induced nephropathy following chronic total occlusion percutaneous coronary intervention in patients with chronic kidney disease.
    Liu YH; Liu Y; Tan N; Chen JY; Zhou YL; Luo JF; Yu DQ; Li LW; Li HL; Ye P; Ran P
    Eur Radiol; 2015 Aug; 25(8):2274-81. PubMed ID: 25981215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of contrast-induced nephropathy in patients undergoing complex percutaneous coronary intervention.
    Azzalini L; Poletti E; Lombardo F; Laricchia A; Beneduce A; Moscardelli S; Bellini B; Maccagni D; Cappelletti A; Ancona MB; Carlino M; Chieffo A; Colombo A; Montorfano M
    Int J Cardiol; 2019 Sep; 290():59-63. PubMed ID: 31005417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inverse correlation between left ventricular end-diastolic pressure and contrast-induced nephropathy in patients undergoing percutaneous coronary intervention.
    Gu G; Xing H; Zhou Y; Cui W
    Clin Exp Nephrol; 2018 Aug; 22(4):808-814. PubMed ID: 29196838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of acute renal failure post-contrast imaging in cardiology: a randomized study.
    Alessandri N; Lanzi L; Garante CM; Tersigni F; Sergiacomi R; Petrassi M; Di Matteo A; Tufano F
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17 Suppl 1():13-21. PubMed ID: 23436661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk scoring system for prediction of contrast-induced nephropathy in patients with pre-existing renal impairment undergoing percutaneous coronary intervention.
    Chong E; Shen L; Poh KK; Tan HC
    Singapore Med J; 2012 Mar; 53(3):164-9. PubMed ID: 22434288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of vascular access on the development of contrast induced nephropathy in patients undergoing coronary angiography and/or percutaneous coronary intervention.
    Barbieri L; Verdoia M; Suryapranata H; De Luca G;
    Int J Cardiol; 2019 Jan; 275():48-52. PubMed ID: 30274753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.